There’s always something new and exciting going on at INTERPHEX. Check out our announcements for the very latest news.

Share This:



NEW YORK, NY; February 25, 2020International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, and Pharmaceutical Technology® andBioPharm International®, two leading information sources for the global drug development and manufacturing community, today released the Keynote Series program for 2020. The Keynote Series features industry experts sharing expertise on industry trends, challenges and solutions to cost effectively develop and manufacture quality product. INTERPHEX takes place April 28-30, 2020 at the Javits Center, New York, NY.

Keynote Series, Innovation Stage, #1281
Tuesday, April 28, 2020, 10:30am – 12:00pm

“Commercialization Challenges for Cell and Gene Therapies”
The early promise offered by cell therapies and gene therapies is tempered by the challenges associated with developing, manufacturing, and delivering the drug product to patients. The complexities of producing these therapies are testing established practices, from starting materials—to process development to cGMP compliance to supply chain security and reliability. This session will highlight technical and regulatory hurdles associated with development and manufacturing steps, and strategies and solutions to facilitate development through commercialization steps. The discussion will include a focus on data management and scheduling strategies to guarantee transparency and chains of authenticity and custody for personalized therapies.

Panelists: Mark Sawicki, Chief Commercial Officer, Cryoport; Chris Murphy, Vice President/General Manager, Viral Vector Services, Thermo Fisher Scientific; Amy DuRoss, Chief Executive Officer, Vineti; Alberto Santagostino, Senior Vice President, Head of Cell and Gene Therapy, Lonza
Moderators: Rita Peters, Director; Feliza Mirasol, Science Editor both with Pharmaceutical Technology® and BioPharm International®

Tuesday, April 28, 2020, 1:15pm – 3:00pm

“GMPs and Creating a Quality Culture”
Recent FDA warning letters — often received years after inspectors first noticed the problems in 483s — have identified deficiencies in many pharma company quality systems, as well as failures to understand the root causes of recurring problems. In this session, experts will examine typical gaps in performance and how to prevent them from resulting in costly quality and compliance problems.

Panelists: Tim Croft, Vice President, Client Solutions, NSF International, Health Sciences; Additional speakers forthcoming
Moderator: Agnes Shanley, Senior Editor, Pharmaceutical Technology® and BioPharm International®

Wednesday, April 29, 2020, 11:15am – 12:30pm

“Technology Advances in Process Operations: Panel Discussion on How to Use Real-time Monitoring and AI to Optimize Manufacturing Operations”
Today’s technology gives manufacturers the ability to collect and analyze large amounts of process data in real-time. How can artificial intelligence and machine learning can be employed to optimize bio/pharma manufacturing? What is a digital twin and how are early adopters using it? How is predictive maintenance being used in pharmaceutical manufacturing? What lessons can pharma learn from other industries? An expert panel will consider these questions and discuss best practices and the next steps forward for bio/pharma manufacturing.

Panelists: Pamela Docherty, Life Sciences Industry Manager, Siemens; Amos Dor, General Manager, Pharma Team, Automation Products Group, Applied Materials; Bikash Chatterjee, Chief Operations and Science Officer, Pharmatech Associates; Bob Lenich, Global Life Sciences Director, Emerson
Moderator: Jennifer Markarian, Manufacturing Editor, Pharmaceutical Technology® and BioPharm International®

Wednesday, April 29, 2020, 1:15pm – 3:00pm

“Genotoxic Impurities and Drug Quality: Lessons from the Nitrosamine Contamination Crisis”
The discovery of genotoxic contaminants in commonly used prescription and OTC medicines over the past two years triggered expensive recalls and raised important questions about the safety of drug ingredients, testing procedures, and the supply chain for tracking materials and finished drug products.  Public health questions remain unanswered.  Speakers share best practices for identifying impurities and experiences with testing, and discuss the roles and responsibilities of ingredients suppliers, drug manufacturers, and regulatory authorities.

Panelists: David Light, Chief Executive Officer, Valisure; Additional speakers forthcoming
Moderator: Agnes Shanley, Senior Editor, Pharmaceutical Technology® and BioPharm International®

To learn more about the INTERPHEX Technical Conference, here.

Register Today
Attend the full Keynote Series at no cost; Register today for INTERPHEX 2020 and save with the early bird discount. Media who would like to cover the Technical Conference should contact INTERPHEX offers the opportunity to network with leading suppliers and industry professionals, see the latest advancements in technology and equipment and face to face discussions with subject matter experts.

About Pharmaceutical Technology®
Pharmaceutical Technology® is a multimedia platform that provides professionals in the global pharmaceutical manufacturing drug development community with dynamic and reliable cutting-edge, peer-reviewed content and features on next-generation process development and manufacturing, formulation, drug delivery, ingredients, regulation, analytics, packaging, supply chain and outsourcing. Pharmaceutical Technology® also provides comprehensive coverage of international regulations and business trends related to drug development. Pharmaceutical Technology® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

About BioPharm International®
BioPharm International® integrates the science and business of biopharmaceutical research, development and manufacturing. BioPharm International® is a multimedia peer-reviewed resource on technical solutions to help biopharmaceutical professionals succeed in their work. This digital platform features peer-reviewed papers, technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology, bioprocessing and all topics related to pharma manufacturing. BioPharm International® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

For 41 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,000 global industry professionals and 625+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and TwitterIPX Blog continues the learning beyond the show floor. For more information, visit